(Date:7/8/2008)...following statement was issued,today by the law fi...otice is hereby given that a class action lawsuit ...the Middle District of Tennessee on behalf,of all ...q: HWAY ),("Healthways" or the "Company") from Oc...e (the "Class Period")., If you wish to discuss t...
(Date:7/8/2008)...elays in Oxygen Orders, Lack of,Trained Technician... -- The new Medicare,competitive bidding program f...nd chaos for beneficiaries, physicians, hospital d...viders across the country since it,was implemented... program has triggered widespread disruptions in s...
(Date:7/8/2008)...ociety of Hematology (ASH) is proud to announce th... Pathway Grant. The grant is given to training pro...plementation of novel hematology-related training ...sity, Donald Mahoney Jr., MD, of Baylor College of...Sinai School of Medicine, will each receive the gr...
(Date:7/8/2008)...os Innovation,s Proprietary,Device-Free Remote Mo... and Medical Costs, N...ovations, a pioneer,in assisting clients to achiev...ce improvement through a device-free remote monito...e Iowa Medicaid Congestive Heart Failure,Populatio...
Breaking Medicine News(10 mins):Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 2Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3(Date:7/7/2008)...des ANA598 and ANA773 Acting via Independ... Conference Call Today at 2:00 PM PDT, ...s Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced...of the Toll-Like Receptor-7 (TLR7) mechanism for t...linical pharmacology testing,and the results of co...
(Date:7/7/2008).../ -- GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX),...al,company specializing in the prevention and trea...erational update on the company,s progress,towards...l testing and,plans to proceed into therapeutic hu...human trials evaluating GeoVax AIDS vaccines have ...
(Date:7/7/2008)...Top Performer in the Body, SEATTLE, July 7 /PRNew... comes to their antioxidant powers in the body: ki...mpared to other antioxidant-rich fruits and,berrie...ournal of the,American College of Nutrition., Ant...ed flavonoids that,may have the power to neutraliz...
(Date:7/3/2008)...Newswire/ -- All newborn infants,should be screene...irth,according to a new recommendation from the U...tion and the accompanying summary of evidence appe...hose hearing is impaired at birth, during infancy ...l and nonverbal communication and,social skills, i...
Breaking Medicine Technology:Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5Kiwifruit: Antioxidant Power in Quantity and Quality 2Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome 2358 1Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome 2358 2Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome 2358 3LeMaitre Vascular Acquires Biomateriali a Vascular Graft Manufacturer 2355 1LeMaitre Vascular Acquires Biomateriali a Vascular Graft Manufacturer 2355 2LeMaitre Vascular Acquires Biomateriali a Vascular Graft Manufacturer 2355 3Manor Care To Vigorously Contest TRO 8681 1Manor Care To Vigorously Contest TRO 8681 2Kaiser Permanente Group Health Study Shows Depression Worsens HIV Treatment 1110 1Kaiser Permanente Group Health Study Shows Depression Worsens HIV Treatment 1110 2Kaiser Permanente Group Health Study Shows Depression Worsens HIV Treatment 1110 3...monstrate Significant Survival Benefit in,Liver Ca...ll/ -- Bayer,HealthCare Pharmaceuticals Inc. and O...avar(R) (sorafenib) tablets significantly,extended...carcinoma,(HCC), or primary liver cancer versus th...). Results were presented at the 43rd,annual meeti...
...NESS WIRE)--Jun 4, 2007 - GenVec, Inc.,(Nasdaq: GN...y and,efficacy data from the clinical development ...nted in a poster session on,gastrointestinal cance...linical Oncology in Chicago, IL by Dr. Mitchell Po...sion of the posters then,concluded the Saturday mo...
Other Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 2GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 3GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 4...igation system for ENT, cranial and spine procedur...y, critical zones visible during tracking. Image f...n freezes image, snapshot can be taken of frozen i...the microscope, low profile receiver attachment. A...
The spinal system neon is a modular system for posterior stabilization. Its application range extends from occipitocervical via cervical to cervicothoracic applications. In the case of children, it c
Bacon Cranial Rongeur
Cushing Pituitary Rongeur
Medicine Products: